Cargando…
Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway
INTRODUCTION: As the primary immune cells, macrophages play a key role in atherosclerotic progression. M2 macrophage polarization has been reported to promote tissue repair and attenuate plaque formation upon the expression of anti-inflammatory factors. Convallatoxin (CNT) is a natural cardiac glyco...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914072/ https://www.ncbi.nlm.nih.gov/pubmed/33654384 http://dx.doi.org/10.2147/DDDT.S288728 |
_version_ | 1783656950387441664 |
---|---|
author | Zhang, Yi Shi, Xiujin Han, Jialun Peng, Wenxing Fang, Zhenwei Zhou, Yang Xu, Xiaoyu Lin, Jie Xiao, Fucheng Zhao, Limin Lin, Yang |
author_facet | Zhang, Yi Shi, Xiujin Han, Jialun Peng, Wenxing Fang, Zhenwei Zhou, Yang Xu, Xiaoyu Lin, Jie Xiao, Fucheng Zhao, Limin Lin, Yang |
author_sort | Zhang, Yi |
collection | PubMed |
description | INTRODUCTION: As the primary immune cells, macrophages play a key role in atherosclerotic progression. M2 macrophage polarization has been reported to promote tissue repair and attenuate plaque formation upon the expression of anti-inflammatory factors. Convallatoxin (CNT) is a natural cardiac glycoside with anti-inflammatory pharmacological properties. However, whether CNT protects against atherosclerosis (AS) and underlying mechanisms is unknown. This work was designed to explore the potential effects of CNT on atherosclerosis. METHODS: In this study, Apolipoprotein E deficiency (ApoE(−/-)) mice fed with high-fat diet were established, and CNT (50 or 100 μg/kg) were intragastrically administrated for 12 weeks every day. In vitro, RAW264.7 macrophages stimulated with ox-LDL were treated with CNT (50 or 100 nM) for 24 h. The specific PPARγ antagonist, GW9662, was used to block the PPARγ signaling pathway in vitro. Then, the atherosclerotic lesions, macrophage polarization markers, inflammatory cytokines and PPARγ signaling pathway were examined in further examinations. RESULTS: Our results showed that the atherosclerotic lesions were reduced by CNT, as demonstrated by the downregulation of serum lipid level and aortic plaque area in AS mice. Furthermore, we found that CNT treatment promoted the expression of M2 macrophage markers (Arg1, Mrc1, Retnla and Chi3l3), and decreased the levels of pro-inflammatory cytokines (IL-6 and TNF-α), accompanied by the increase of anti-inflammatory factor (IL-10) in aortic vessels of AS mice. In ox-LDL-induced RAW264.7 cells, CNT administration also facilitated macrophages polarizing towards M2 subtype and inhibited inflammatory responses. Furthermore, both the in vivo and in vitro experiments showed CNT could increase the expression of PPARγ, Integrin α(v) and Integrin β(5), and GW9662 could block CNT-induced M2 macrophage polarization. CONCLUSION: Taken together, these data suggest that CNT may promote M2 macrophage polarization to exert an anti-atherosclerotic effect, partially through activating PPARγ-Integrin α(v)β(5) signaling pathway. |
format | Online Article Text |
id | pubmed-7914072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-79140722021-03-01 Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway Zhang, Yi Shi, Xiujin Han, Jialun Peng, Wenxing Fang, Zhenwei Zhou, Yang Xu, Xiaoyu Lin, Jie Xiao, Fucheng Zhao, Limin Lin, Yang Drug Des Devel Ther Original Research INTRODUCTION: As the primary immune cells, macrophages play a key role in atherosclerotic progression. M2 macrophage polarization has been reported to promote tissue repair and attenuate plaque formation upon the expression of anti-inflammatory factors. Convallatoxin (CNT) is a natural cardiac glycoside with anti-inflammatory pharmacological properties. However, whether CNT protects against atherosclerosis (AS) and underlying mechanisms is unknown. This work was designed to explore the potential effects of CNT on atherosclerosis. METHODS: In this study, Apolipoprotein E deficiency (ApoE(−/-)) mice fed with high-fat diet were established, and CNT (50 or 100 μg/kg) were intragastrically administrated for 12 weeks every day. In vitro, RAW264.7 macrophages stimulated with ox-LDL were treated with CNT (50 or 100 nM) for 24 h. The specific PPARγ antagonist, GW9662, was used to block the PPARγ signaling pathway in vitro. Then, the atherosclerotic lesions, macrophage polarization markers, inflammatory cytokines and PPARγ signaling pathway were examined in further examinations. RESULTS: Our results showed that the atherosclerotic lesions were reduced by CNT, as demonstrated by the downregulation of serum lipid level and aortic plaque area in AS mice. Furthermore, we found that CNT treatment promoted the expression of M2 macrophage markers (Arg1, Mrc1, Retnla and Chi3l3), and decreased the levels of pro-inflammatory cytokines (IL-6 and TNF-α), accompanied by the increase of anti-inflammatory factor (IL-10) in aortic vessels of AS mice. In ox-LDL-induced RAW264.7 cells, CNT administration also facilitated macrophages polarizing towards M2 subtype and inhibited inflammatory responses. Furthermore, both the in vivo and in vitro experiments showed CNT could increase the expression of PPARγ, Integrin α(v) and Integrin β(5), and GW9662 could block CNT-induced M2 macrophage polarization. CONCLUSION: Taken together, these data suggest that CNT may promote M2 macrophage polarization to exert an anti-atherosclerotic effect, partially through activating PPARγ-Integrin α(v)β(5) signaling pathway. Dove 2021-02-23 /pmc/articles/PMC7914072/ /pubmed/33654384 http://dx.doi.org/10.2147/DDDT.S288728 Text en © 2021 Zhang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhang, Yi Shi, Xiujin Han, Jialun Peng, Wenxing Fang, Zhenwei Zhou, Yang Xu, Xiaoyu Lin, Jie Xiao, Fucheng Zhao, Limin Lin, Yang Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway |
title | Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway |
title_full | Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway |
title_fullStr | Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway |
title_full_unstemmed | Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway |
title_short | Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin α(v)β(5) Signaling Pathway |
title_sort | convallatoxin promotes m2 macrophage polarization to attenuate atherosclerosis through pparγ-integrin α(v)β(5) signaling pathway |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914072/ https://www.ncbi.nlm.nih.gov/pubmed/33654384 http://dx.doi.org/10.2147/DDDT.S288728 |
work_keys_str_mv | AT zhangyi convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway AT shixiujin convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway AT hanjialun convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway AT pengwenxing convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway AT fangzhenwei convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway AT zhouyang convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway AT xuxiaoyu convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway AT linjie convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway AT xiaofucheng convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway AT zhaolimin convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway AT linyang convallatoxinpromotesm2macrophagepolarizationtoattenuateatherosclerosisthroughppargintegrinavb5signalingpathway |